Photoluminescent properties of liposome-encapsulated amine-functionalized nanodiamonds

被引:6
|
作者
Douda, J. [1 ]
Gonzalez-Vargas, C. R. [1 ,2 ]
Mota-Diaz, I. I. [1 ]
Basiuk, E., V [3 ]
Hernandez-Contreras, X. A. [1 ]
Fuentes-Garcia, J. A. [1 ,4 ]
Bornacelli, J. [5 ]
Torres-Torres, C. [5 ]
机构
[1] UPIITA Inst Politecn Nacl, Othon Mendizabal S-N, Cd Mexico 07320, Mexico
[2] Univ Paris Saclay, ISMO Inst Sci Mol Orsay, CNRS, F-91405 Orsay, France
[3] Univ Nacl Aut6noma Mexico, ICAT Inst Ciencias Aplicadas & Tecnol, Circuito Exterior CU, Cd Mexico 04510, Mexico
[4] Univ Zaragoza, INMA Inst Nanociencia & Mat Aragon, Mariano Esquillor S-N, Zaragoza, Spain
[5] Inst Politecn Nacl, ESIME Zac, Othon Mendizabal S-N, Cd Mexico 07738, Mexico
来源
NANO EXPRESS | 2020年 / 1卷 / 03期
基金
欧盟地平线“2020”;
关键词
nanodiamonds; biosensors; theranostic liposome; photoluminescence; all-optical sensors; FREE COVALENT FUNCTIONALIZATION; GRAPHENE OXIDE; OPTICAL-PROPERTIES; DRUG-DELIVERY; QUANTUM DOTS; NANOCOMPOSITES; NANOPARTICLES; DEFECTS;
D O I
10.1088/2632-959X/abc1c5
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
In the present work, amine-functionalized nanodiamonds (NDs) have been encapsulated in liposomes and studied in order to observe the modification of their photoluminescence properties. NDs were functionalized with aromatic amines such as 1-aminopyrene and 2-aminofluorene, and the aliphatic amine 1-octadecylamine. Morphology, structural and optical properties of NDs and amine-modified NDs were analyzed by transmission electron microscopy, atomic force microscopy, scanning electron microscopy, and photoluminescence. The amine-functionalized NDs were successfully encapsulated in lecithin liposomes prepared by the green and conventional methods. The obtained results show significant changes in photoluminescent properties of functionalized NDs, and were more potentialized after liposome encapsulation. Our findings could be applied in the development of new kinds of water-dispersible fluorescent hybrids, liposome-NDs, with the capability of drug encapsulation for use in diagnostics and therapy (theragnostic liposomes). All-optical sensors with possibilities for tailoring their response for other biomedical applications can be also contemplated.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Interaction of liposome-encapsulated cisplatin with biomolecules
    Baruah, Bharat
    Surin, Alexandr
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2012, 17 (06): : 899 - 910
  • [22] Optimization of selected liposome-encapsulated diketopiperazines
    Kilian, G.
    Milne, P.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2014, 24 (02) : 143 - 147
  • [23] TARGETING HIV WITH LIPOSOME-ENCAPSULATED ANTIVIRALS
    DESORMEAUX, A
    BERGERON, MG
    ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1995, 282 (03): : 225 - 231
  • [24] LIPOSOME-ENCAPSULATED HEMOGLOBIN PROCESSING METHODS
    ZHENG, SM
    ZHENG, YM
    BEISSINGER, RL
    FRESCO, R
    BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4): : 355 - 364
  • [25] USE OF LIPOSOME-ENCAPSULATED DRUGS IN LEISHMANIASIS
    ALVING, CR
    STECK, EA
    TRENDS IN BIOCHEMICAL SCIENCES, 1979, 4 (08) : N175 - N177
  • [26] EXAFS study of liposome-encapsulated cisplatin
    Arcon, I
    Kodre, A
    Abra, RM
    Huang, A
    Vallner, JJ
    Lasic, DD
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2004, 33 (3-4) : 199 - 204
  • [27] DELIVERY OF LIPOSOME-ENCAPSULATED DRUGS TO MACROPHAGES
    ALVING, CR
    PHARMACOLOGY & THERAPEUTICS, 1983, 22 (03) : 407 - 424
  • [28] LIPOSOME-ENCAPSULATED DTPA IN PLUTONIUM THERAPY
    ROSENTHAL, MW
    RAHMAN, YE
    RADIATION RESEARCH, 1974, 59 (01) : 134 - 134
  • [29] Liposome-encapsulated midazolam for oral administration
    Tomoyasu, Yumiko
    Yasuda, Tatsuji
    Maeda, Shigeru
    Higuchi, Hitoshi
    Miyawaki, Takuya
    JOURNAL OF LIPOSOME RESEARCH, 2011, 21 (02) : 166 - 172
  • [30] Topical anesthesia of liposome-encapsulated tetracaine
    Hung, OR
    Comeau, L
    Riley, M
    Tan, S
    Whynot, S
    Mezei, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI9 - PI9